Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13484 | 833 | 32.2 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
501 | 3 | SYSTEMIC SCLEROSIS//SCLERODERMA//IDIOPATHIC PULMONARY FIBROSIS | 22108 |
884 | 2 | SYSTEMIC SCLEROSIS//SCLERODERMA//RAYNAUDS PHENOMENON | 11430 |
13484 | 1 | ANTICENTROMERE ANTIBODIES//SYSTEMIC SCLEROSIS//ANTITOPOISOMERASE I ANTIBODIES | 833 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTICENTROMERE ANTIBODIES | authKW | 751872 | 5% | 51% | 40 |
2 | SYSTEMIC SCLEROSIS | authKW | 282512 | 19% | 5% | 160 |
3 | ANTITOPOISOMERASE I ANTIBODIES | authKW | 281571 | 2% | 59% | 13 |
4 | SCLERODERMA | authKW | 179448 | 12% | 5% | 97 |
5 | ANTINUCLEOLAR ANTIBODIES | authKW | 164947 | 1% | 75% | 6 |
6 | ANTI TOPOISOMERASE I | authKW | 163279 | 1% | 64% | 7 |
7 | PM SCL | authKW | 152730 | 1% | 83% | 5 |
8 | ANTI CENTROMERE ANTIBODY | authKW | 146615 | 1% | 50% | 8 |
9 | ANTI RNA POLYMERASE III ANTIBODIES | authKW | 117296 | 0% | 80% | 4 |
10 | NOR 90 | authKW | 109967 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Rheumatology | 58012 | 48% | 0% | 398 |
2 | Immunology | 1116 | 19% | 0% | 157 |
3 | Dermatology | 610 | 7% | 0% | 58 |
4 | Medicine, General & Internal | 312 | 10% | 0% | 87 |
5 | Medical Laboratory Technology | 295 | 3% | 0% | 28 |
6 | Medicine, Research & Experimental | 120 | 6% | 0% | 47 |
7 | Pathology | 81 | 3% | 0% | 29 |
8 | Genetics & Heredity | 18 | 3% | 0% | 29 |
9 | Allergy | 10 | 1% | 0% | 6 |
10 | Cell Biology | 3 | 3% | 0% | 27 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | F MAGRASSI A LANZARA CLIN EXPT INTERNAL ME | 73311 | 0% | 100% | 2 |
2 | INTERNAL MED DIMO | 73311 | 0% | 100% | 2 |
3 | RHEUMATOL UNIT CHAIR | 41234 | 0% | 38% | 3 |
4 | ALLIED HLTH SCI IMMUNOL | 36656 | 0% | 100% | 1 |
5 | ARTHRIT MED | 36656 | 0% | 100% | 1 |
6 | ARTRITIS IMMUNOL PROGRAM | 36656 | 0% | 100% | 1 |
7 | AUSTRALIAN SCLERODERMA INTE T GRP | 36656 | 0% | 100% | 1 |
8 | BASIC TECHNOL SUBDIRECT | 36656 | 0% | 100% | 1 |
9 | BIOMED CORDELIERS CYTOGENET EXPTL | 36656 | 0% | 100% | 1 |
10 | BLOOD TRANSFUS SERV DNA TYPING | 36656 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ARTHRITIS AND RHEUMATISM | 27672 | 11% | 1% | 88 |
2 | JOURNAL OF RHEUMATOLOGY | 13672 | 8% | 1% | 69 |
3 | AUTOIMMUNITY REVIEWS | 6268 | 2% | 1% | 17 |
4 | BRITISH JOURNAL OF RHEUMATOLOGY | 5348 | 2% | 1% | 18 |
5 | ARTHRITIS RESEARCH & THERAPY | 4926 | 3% | 1% | 21 |
6 | ANNALS OF THE RHEUMATIC DISEASES | 3926 | 4% | 0% | 31 |
7 | CLINICAL RHEUMATOLOGY | 3607 | 3% | 0% | 23 |
8 | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 3499 | 3% | 0% | 23 |
9 | CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2899 | 4% | 0% | 30 |
10 | JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY | 2098 | 1% | 1% | 8 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTICENTROMERE ANTIBODIES | 751872 | 5% | 51% | 40 | Search ANTICENTROMERE+ANTIBODIES | Search ANTICENTROMERE+ANTIBODIES |
2 | SYSTEMIC SCLEROSIS | 282512 | 19% | 5% | 160 | Search SYSTEMIC+SCLEROSIS | Search SYSTEMIC+SCLEROSIS |
3 | ANTITOPOISOMERASE I ANTIBODIES | 281571 | 2% | 59% | 13 | Search ANTITOPOISOMERASE+I+ANTIBODIES | Search ANTITOPOISOMERASE+I+ANTIBODIES |
4 | SCLERODERMA | 179448 | 12% | 5% | 97 | Search SCLERODERMA | Search SCLERODERMA |
5 | ANTINUCLEOLAR ANTIBODIES | 164947 | 1% | 75% | 6 | Search ANTINUCLEOLAR+ANTIBODIES | Search ANTINUCLEOLAR+ANTIBODIES |
6 | ANTI TOPOISOMERASE I | 163279 | 1% | 64% | 7 | Search ANTI+TOPOISOMERASE+I | Search ANTI+TOPOISOMERASE+I |
7 | PM SCL | 152730 | 1% | 83% | 5 | Search PM+SCL | Search PM+SCL |
8 | ANTI CENTROMERE ANTIBODY | 146615 | 1% | 50% | 8 | Search ANTI+CENTROMERE+ANTIBODY | Search ANTI+CENTROMERE+ANTIBODY |
9 | ANTI RNA POLYMERASE III ANTIBODIES | 117296 | 0% | 80% | 4 | Search ANTI+RNA+POLYMERASE+III+ANTIBODIES | Search ANTI+RNA+POLYMERASE+III+ANTIBODIES |
10 | NOR 90 | 109967 | 0% | 100% | 3 | Search NOR+90 | Search NOR+90 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MEHRA, S , WALKER, J , PATTERSON, K , FRITZLER, MJ , (2013) AUTOANTIBODIES IN SYSTEMIC SCLEROSIS.AUTOIMMUNITY REVIEWS. VOL. 12. ISSUE 3. P. 340-354 | 101 | 40% | 51 |
2 | REVEILLE, JD , SOLOMON, DH , (2003) EVIDENCE-BASED GUIDELINES FOR THE USE OF IMMUNOLOGIC TESTS: ANTICENTROMERE, SCL-70, AND NUCLEOLAR ANTIBODIES.ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH. VOL. 49. ISSUE 3. P. 399-412 | 77 | 73% | 116 |
3 | HAMAGUCHI, Y , (2010) AUTOANTIBODY PROFILES IN SYSTEMIC SCLEROSIS: PREDICTIVE VALUE FOR CLINICAL EVALUATION AND PROGNOSIS.JOURNAL OF DERMATOLOGY. VOL. 37. ISSUE 1. P. 42 -53 | 66 | 67% | 60 |
4 | PEROSA, F , PRETE, M , DI LERNIA, G , OSTUNI, C , FAVOINO, E , VALENTINI, G , (2016) ANTI-CENTROMERE PROTEIN A ANTIBODIES IN SYSTEMIC SCLEROSIS: SIGNIFICANCE AND ORIGIN.AUTOIMMUNITY REVIEWS. VOL. 15. ISSUE 1. P. 102 -109 | 68 | 56% | 0 |
5 | HO, KT , REVEILLE, JD , (2003) THE CLINICAL RELEVANCE OF AUTOANTIBODIES IN SCLERODERMA.ARTHRITIS RESEARCH & THERAPY. VOL. 5. ISSUE 2. P. 80 -93 | 71 | 58% | 117 |
6 | FABIEN, N , ROUSSET, H , (2002) IMMUNOLOGICAL DIAGNOSTIC OF SCLERODERMA.PATHOLOGIE BIOLOGIE. VOL. 50. ISSUE 4. P. 243 -255 | 66 | 73% | 4 |
7 | OKANO, Y , (1996) ANTINUCLEAR ANTIBODY IN SYSTEMIC SCLEROSIS (SCLERODERMA).RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. VOL. 22. ISSUE 4. P. 709-& | 79 | 62% | 101 |
8 | MIERAU, R , MOINZADEH, P , RIEMEKASTEN, G , MELCHERS, I , MEURER, M , REICHENBERGER, F , BUSLAU, M , WORM, M , BLANK, N , HEIN, R , ET AL (2011) FREQUENCY OF DISEASE-ASSOCIATED AND OTHER NUCLEAR AUTOANTIBODIES IN PATIENTS OF THE GERMAN NETWORK FOR SYSTEMIC SCLERODERMA: CORRELATION WITH CHARACTERISTIC CLINICAL FEATURES.ARTHRITIS RESEARCH & THERAPY. VOL. 13. ISSUE 5. P. - | 47 | 61% | 39 |
9 | DICK, T , MIERAU, R , BARTZ-BAZZANELLA, P , ALAVI, M , STOYANOVA-SCHOLZ, M , KINDLER, J , GENTH, E , (2002) COEXISTENCE OF ANTITOPOISOMERASE I AND ANTICENTROMERE ANTIBODIES IN PATIENTS WITH SYSTEMIC SCLEROSIS.ANNALS OF THE RHEUMATIC DISEASES. VOL. 61. ISSUE 2. P. 121 -127 | 50 | 79% | 30 |
10 | MAHLER, M , MAES, L , BLOCKMANS, D , WESTHOVENS, R , BOSSUYT, X , RIEMEKASTEN, G , SCHNEIDER, S , HIEPE, F , SWART, A , GURTLER, I , ET AL (2010) CLINICAL AND SEROLOGICAL EVALUATION OF A NOVEL CENP-A PEPTIDE BASED ELISA.ARTHRITIS RESEARCH & THERAPY. VOL. 12. ISSUE 3. P. - | 35 | 80% | 8 |
Classes with closest relation at Level 1 |